Validating Adverse Events On A Large Scale
Publié le
Adverse Events coded by IDDI Medical Coding System Two pivotal trials were conducted (one in the US, one in Europe)…
Publié le
Adverse Events coded by IDDI Medical Coding System Two pivotal trials were conducted (one in the US, one in Europe)…
Publié le
A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…
Publié le
Biomarker Analysis with the Mixed Modelling Methodology Two doses of a therapeutic vaccine were tested simultaneously in a randomized phase II…
Publié le
Meta-Analysis performed with IDDI’s Methodology Skills IDDI has been involved in numerous meta-analyses to directly or indirectly support new drug applications….
Publié le
IDDI announces the appointment of Dr. Everardo Saad as Senior Medical Expert as of July 2014. Everardo brings over 12 years…
Publié le
IDDI, an international functional Contract Research Organisation (CRO) headquartered in Belgium, replaced its mix of a paper-based trial master file…
Publié le
A new Software for Risk-based Monitoring As biopharmaceutical sponsors search for the optimal approach to targeted monitoring and reduced Source…
Publié le
Central Statistical Monitoring of Data Quality in Clinical Trials IDDI announces publication on Central Statistical Monitoring: ‘A statistical approach to central…
Publié le
Integrated EDC IWRS system: The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system. …